146 related articles for article (PubMed ID: 9413197)
1. Targeted vinblastine chemotherapy with two preparations of lipiodol contrast medium.
Oda T; Konno T; Nagamitsu A; Tabaru K; Maeda H; Kitamura N
Anticancer Res; 1997; 17(5A):3521-9. PubMed ID: 9413197
[TBL] [Abstract][Full Text] [Related]
2. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
Konno T; Maeda H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor.
Hayashi Y; Fukushima S; Kishimoto S; Kawaguchi T; Numata M; Isoda Y; Hirano J; Nakano M
Cancer Res; 1992 Jan; 52(2):400-5. PubMed ID: 1309442
[TBL] [Abstract][Full Text] [Related]
4. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier].
Konno T; Oda T; Nagamitsu A; Tabaru K; Yamashita R; Kai Y
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762
[TBL] [Abstract][Full Text] [Related]
5. Treatment of VX2 carcinoma implanted in the liver with arterial and intraperitoneal administration of oily anticancer agents.
Tabaru K; Konno T; Oda T; Nagamitsu A; Ishimaru Y; Kitamura N
Cancer Chemother Pharmacol; 2001; 47(2):149-54. PubMed ID: 11269741
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
[TBL] [Abstract][Full Text] [Related]
7. [Targeting of anticancer chemotherapy utilizing the characteristic nature of the neovasculature of solid tumors].
Konno T; Ohtsuka N; Yamasaki K; Mizutani J; Miyauchi Y; Maeda H; Matsumura Y
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1448-55. PubMed ID: 2425743
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium.
Konno T
Cancer; 1990 Nov; 66(9):1897-903. PubMed ID: 2171752
[TBL] [Abstract][Full Text] [Related]
9. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
10. [Basic and clinical study of liver cancer using intra-arterial infusion of an emulsion of the oily contrast medium lipiodol with 5-FU].
Tada I; Kobayashi M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1938-9. PubMed ID: 2996440
[TBL] [Abstract][Full Text] [Related]
11. Selective anticancer effects of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine, a lipophilic prodrug of 5-fluoro-2'-deoxyuridine, dissolved in an oily lymphographic agent on hepatic cancer of rabbits bearing VX-2 tumor.
Fukushima S; Kawaguchi T; Nishida M; Juni K; Yamashita Y; Takahashi M; Nakano M
Cancer Res; 1987 Apr; 47(7):1930-4. PubMed ID: 3028618
[TBL] [Abstract][Full Text] [Related]
12. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
Oda T; Konno T; Ohtsuka N; Kimura M; Mizumachi R
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
[TBL] [Abstract][Full Text] [Related]
14. Intracavitary treatment of malignant ascitic carcinomatosis with oily anticancer agents in rats.
Kimura M; Konno T; Oda T; Maeda H; Miyauchi Y
Anticancer Res; 1993; 13(5A):1287-92. PubMed ID: 8239499
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
[TBL] [Abstract][Full Text] [Related]
16. [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
Maeda H; Konno T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):773-82. PubMed ID: 2985005
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
18. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
19. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
Lin WY; Chi CW; Ho YJ; Wu IC; Chung YT; Chen SD; Chou FI; Kai JJ; Lui WY; Chen TJ; Lin Y
Anticancer Res; 2002; 22(6C):3989-92. PubMed ID: 12553023
[TBL] [Abstract][Full Text] [Related]
20. Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study.
de Baere T; Zhang X; Aubert B; Harry G; Lagrange C; Ropers J; Dufaux J; Lumbroso J; Rougier P; Ducreux M; Roche A
Radiology; 1996 Dec; 201(3):731-5. PubMed ID: 8939223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
